Sage Rhino Capital’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,299
Closed -$488K 232
2021
Q3
$488K Buy
6,299
+111
+2% +$8.35K 0.15% 109
2021
Q2
$443K Buy
6,188
+514
+9% +$37.4K 0.13% 121
2021
Q1
$384K Sell
5,674
-10
-0.2% -$694 0.13% 119
2020
Q4
$416K Buy
5,684
+4
+0.1% +$290 0.16% 104
2020
Q3
$398K Buy
5,680
+419
+8% +$32.9K 0.19% 95
2020
Q2
$383K Sell
5,261
-2,375
-31% -$169K 0.2% 96
2020
Q1
$472K Buy
7,636
+501
+7% +$30.6K 0.34% 63
2019
Q4
$478K Buy
7,135
+2,165
+44% +$149K 0.27% 80
2019
Q3
$393K Buy
+4,970
New +$332K 0.25% 86

Other funds holding CONE

Sage Rhino Capital's CONE Position: Q4 2021 in Review

Sage Rhino Capital sold out of CyrusOne Inc Common Stock (CONE) in Q4 2021, closing a stake of 6,299 shares — an estimated $488K sold.

Sage Rhino Capital first reported a position in CONE in Q3 2019 and held it in 9 quarters. The position peaked at $488K in Q3 2021. 469 funds tracked by Wall St. Rank hold CONE as of Q4 2021.

  • Sage Rhino Capital reported no remaining CyrusOne Inc Common Stock position as of Q4 2021 after selling out during the quarter.
  • Sage Rhino Capital sold 6,299 CyrusOne Inc Common Stock shares in Q4 2021, an estimated $488K.
  • Sage Rhino Capital first reported a position in CyrusOne Inc Common Stock in Q3 2019 and held it in 9 quarters.
  • Sage Rhino Capital's CyrusOne Inc Common Stock position peaked at $488K in Q3 2021.
  • 469 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q4 2021.

Based on Sage Rhino Capital's 13F filing for Q4 2021, filed 4 Feb 2022.